BioAgilytix is a bioanalytical testing laboratory specializing in large molecule bioanalysis. It provides pharmacokinetics (PK), immunogenicity, biomarkers, gene therapy, cell-based assay, diagnostic testing, CAR T-Cell therapy, and other services supporting the development and release testing of biologics. The company serves pharmaceutical and biotech industries.

Employee Rating

3.3More
TypeSubsidiary
HQDurham, NC, US
Founded2008
Websitebioagilytix.com
Cybersecurity ratingAMore
BioAgilytix was founded in 2008 and is headquartered in Durham, NC, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at BioAgilytix

Arno Kromminga

Arno Kromminga

Chief Scientific Advisor
Afshin Safavi

Afshin Safavi

Founder & Board Member
Dominic Marasco

Dominic Marasco

Chief Commercial Officer
Steven M. Michael

Steven M. Michael

Senior Vice President & Chief Operating Officer
Frank Horling

Frank Horling

General Manager, Europe
Linda Robbie

Linda Robbie

Vice President and General Manager, Boston Operations
Show more

BioAgilytix Office Locations

BioAgilytix has offices in Durham, Boston and Hamburg
Durham, NC, US (HQ)
2300 Englert Dr
Boston, MA, US
1320 Soldiers Field Rd
Hamburg, DE
Lademannbogen 10
Show all (3)

BioAgilytix Financials and Metrics

Summary Metrics

Founding Date

2008

Total Funding

$30.2 m

Investors

In total, BioAgilytix had raised $30.2 m

BioAgilytix Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

BioAgilytix Online and Social Media Presence

Embed Graph

BioAgilytix News and Updates

BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

DURHAM, N.C. and BRUSSELS, Belgium and LONDON, Nov. 17, 2021 /PRNewswire/ -- BioAgilytix, a leading global contract research organization (CRO), today announced an agreement to be further capitalized by Cinven, a leading international private investment firm focused on building...

BioAgilytix to Purchase Australia-based 360biolabs速

DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive...

BioAgilytix Blogs

Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge

The post Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.

Utilizing Multiparameter Flow Cytometry in Clinical Trials

The post Utilizing Multiparameter Flow Cytometry in Clinical Trials appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stagesDurham, NC, October 14, 2021 –…

Bioagilytix Announces New Partnership With CTI

Alliance to strengthen both companies’ ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle developmentDurham, NC, October 4, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting…

Molecular Methods for Gene Therapies (GMP)

The post Molecular Methods for Gene Therapies (GMP) appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.

Large Molecule Pharmacokinetic Assays for New Modalities

The post Large Molecule Pharmacokinetic Assays for New Modalities appeared first on Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis.
Show more

BioAgilytix Frequently Asked Questions

  • When was BioAgilytix founded?

    BioAgilytix was founded in 2008.

  • Who are BioAgilytix key executives?

    BioAgilytix's key executives are Arno Kromminga, Afshin Safavi and Dominic Marasco.

  • How many employees does BioAgilytix have?

    BioAgilytix has 624 employees.

  • Who are BioAgilytix competitors?

    Competitors of BioAgilytix include Innovassynth, WuXi Advanced Therapies and Research Institute of Molecular Pathology.

  • Where is BioAgilytix headquarters?

    BioAgilytix headquarters is located at 2300 Englert Dr, Durham.

  • Where are BioAgilytix offices?

    BioAgilytix has offices in Durham, Boston and Hamburg.

  • How many offices does BioAgilytix have?

    BioAgilytix has 3 offices.